XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2

Revenues (Tables)

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2023 and 2022:

			Three months ended June 30,												Six months ended June 30,
			2023						2022						2023						2022
Products:
Kristalose			$	4,110,718					$	3,570,272					$	8,425,846					$	7,515,368
Sancuso			1,916,966						3,398,548						3,803,759						6,795,758
Vibativ			2,147,826						1,596,821						3,996,013						4,098,255
Caldolor			1,226,314						1,193,916						2,161,356						2,153,546
Acetadote			150,163						126,789						320,019						237,884
Vaprisol			23,857						(134,621)						39,866						(251,623)
Omeclamox-Pak			8,062						(26,412)						5,544						(3,676)
RediTrex			9,493						93,676						(131,552)						152,904
Other revenue			1,295,478						480,163						1,492,664						775,781
Total net revenues			$	10,888,877					$	10,299,152					$	20,113,515					$	21,474,197

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration